icarusconsultants.com
Icarus Consultants: Pharma Marketing Strategy, New Products Consulting, Market Intelligence, KOL Market ResearchNew Products Strategy, Market Intelligence & KOL Market Research
http://www.icarusconsultants.com/
New Products Strategy, Market Intelligence & KOL Market Research
http://www.icarusconsultants.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
16x16
Contact Privacy Inc. Customer 0129962969
Contact Privacy Inc. Customer 0129962969
96 M●●●● Ave
To●●to , ON, M6K 3M1
CA
View this contact
Contact Privacy Inc. Customer 0129962969
Contact Privacy Inc. Customer 0129962969
96 M●●●● Ave
To●●to , ON, M6K 3M1
CA
View this contact
Contact Privacy Inc. Customer 0129962969
Contact Privacy Inc. Customer 0129962969
96 M●●●● Ave
To●●to , ON, M6K 3M1
CA
View this contact
BUY YOUR DOMAIN
20
YEARS
4
MONTHS
5
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
87
SITE IP
64.98.145.30
LOAD TIME
0 sec
SCORE
6.2
Icarus Consultants: Pharma Marketing Strategy, New Products Consulting, Market Intelligence, KOL Market Research | icarusconsultants.com Reviews
https://icarusconsultants.com
New Products Strategy, Market Intelligence & KOL Market Research
icarusconsultants.com
What’s Exciting in Cancer Immunotherapy? | Icarus Consultants
http://icarusconsultants.com/whats-exciting-in-cancer-immunotherapy
Pharma New Products Strategy and Market Analysis with a focus on oncology and hematology. Icarus Custom Menu Bar. What’s Exciting in Cancer Immunotherapy? November 14, 2014. A record attendance of over 1500 attendees went to the annual meeting of the Society for Immunotherapy of Cancer (SITC). Last weekend at National Harbor in Maryland to hear about the latest developments in cancer immunotherapy. It’s even more surprising given one of hottest areas in cancer immunotherapy is CAR-T therapy. Th...It’s a ...
CAR-T cell immunotherapy race to market | Icarus Consultants
http://icarusconsultants.com/chimeric-antigen-receptor-cart-immunotherapy-race-to-market
Pharma New Products Strategy and Market Analysis with a focus on oncology and hematology. Icarus Custom Menu Bar. Who will win CAR-T cell immunotherapy race to market? July 9, 2014. Chimeric Antigen Receptor T cell immunotherapy (known as CAR-T or more colloquially as CART) has been in the news recently. As we wrote about on Biotech Strategy Blog, Kite Pharma recently had a highly successful initial public offering (IPO). The data presented at scientific meetings to date has been from small single-center...
Pharma Market Business Competitive Intelligence Services | Icarus Consultants
http://icarusconsultants.com/market-intelligence
Pharma New Products Strategy and Market Analysis with a focus on oncology and hematology. Icarus Custom Menu Bar. August 15, 2012. Why undertake Market, Competitive or Business Intelligence? Competitive Intelligence (CI) provides valuable business, scientific and market insights that help companies achieve and maintain a competitive advantage. Although the term CI is commonly used, we prefer to think of it as market intelligence. Within the pharmaceutical and biotechnology space, we help our clients trac...
Promise of PD1 PDL1 Cancer Immunotherapy | Icarus Consultants
http://icarusconsultants.com/the-promise-of-pd1-pdl1-immunotherapy
Pharma New Products Strategy and Market Analysis with a focus on oncology and hematology. Icarus Custom Menu Bar. The Promise of PD1 PDL1 Immunotherapy. October 31, 2014. Picture of Genentech Immunotherapy Video. The trick then is to unmask the aberrations and hidden mutations in the tumor cells, so that the immune system can recognize the cancer cells as a target. This is what immunotherapy seeks to do, provide a target so that the T cells can attack the cancer. Roche/Genentech have produced an excellen...
Oncology Hematology New Products Commercial Strategy | Icarus Consultants
http://icarusconsultants.com/new-products-strategy
Pharma New Products Strategy and Market Analysis with a focus on oncology and hematology. Icarus Custom Menu Bar. August 15, 2012. Icarus Consultants has particular expertise in working with new products teams. Our staff have worked in new products, as well as in clinical development and marketing. This allows us to understand the clinical data, and relate this to the commercial market opportunity. What is the market opportunity? What is the scientific, clinical and commercial potential of a new product?
TOTAL PAGES IN THIS WEBSITE
7
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: Second-line treatment in CML
http://hematologymarketinsights.blogspot.com/2008/07/second-line-treatment-in-cml.html
Tuesday, July 29, 2008. Second-line treatment in CML. MD Anderson Cancer Center recently published a new article in Blood. Looking at second-line treatment with tyrosine kinase therapies with nilotinib. Failure. This is a crucial question - how long should patients receive their new therapy before considering alternative treatments? Thanks for this useful post. Here is some additional information about the genetics of this condition that was written by our Genetic Counselor and other genetic professi...
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: May 2008
http://hematologymarketinsights.blogspot.com/2008_05_01_archive.html
Monday, May 12, 2008. Knocking out cancer cells in Leukemia. Cancer initiating cells (CICs) or leukemia initiating cells (LICs) are stealth populations impervious to conventional chemotherapy and resistant to targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that are the cause of the disease’s re-emergence. Researchers at the Beth Israel Deaconess Medical Center. Their findings, which appear in Nature. The concept is a very simple one; 90% of exis...
oncologymarkettrends.blogspot.com
Oncology Market Trends: Cancer Research Blog Carnival #14 — Sciencebase Science Blog
http://oncologymarkettrends.blogspot.com/2008/10/cancer-research-blog-carnival-14.html
What's new in the world of cancer. Monday, October 6, 2008. Cancer Research Blog Carnival #14 — Sciencebase Science Blog. Well, this morning I had a nice surprise after finding that some posts in my science and cancer blog made the Cancer Research Blog Carnival. This weekend, thanks to the host David Bradley and ScienceBase. You can read more about this great Carnival concept on his blog. About the online event. Related articles by Zemanta. Cancer Research Blog Carnival. Cancer Research Blog Carnival.
oncologyconsultingnews.blogspot.com
Pharma Market Strategy: When tomorrow never comes... the rising cost of health care
http://oncologyconsultingnews.blogspot.com/2008/10/when-tomorrow-never-comes-rising-cost.html
News and views from the world of pharmaceuticals and biotechnology. Monday, October 13, 2008. When tomorrow never comes. the rising cost of health care. This weekend, I had the opportunity to read Matt Miller’s outstanding upcoming book, The Tyranny of Dead Ideas. What is the world coming to when the cost of basic health care is so exorbitant? The National Coalition on Health Care. Has some startling facts:. Washington's focus on drug costs is in many ways displaced, because like earmarks it represents a...
cancertechinsights.blogspot.com
Cancer Technology and Insights: How is cancer formed?
http://cancertechinsights.blogspot.com/2008/07/how-is-cancer-formed.html
Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Sunday, July 20, 2008. How is cancer formed? All cancers start with mutations in one single cell. The mutations are located in the cell's DNA. And may be inherited, although less than 10% of all cancer mutations are inherited. Usually, the mutation arises as a result of environmental factors. The DNA mutation may be a single nucleotide change, or a deletion or duplication of the DNA sequence. They are replaced...
cancertechinsights.blogspot.com
Cancer Technology and Insights: BRCA mutations in breast cancer
http://cancertechinsights.blogspot.com/2008/07/brca-mutations-in-breast-cancer.html
Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Saturday, July 26, 2008. BRCA mutations in breast cancer. Genetic testing for BRCA1. Mutations can provide important information for women who are concerned about their breast and ovarian cancer risks and need to make relevant prevention and medical management decisions. Cancer risks in a population-based study. Of BRCA1/2 mutation carriers have been recently estimated, but the numbers are still in their infan...
cancertechinsights.blogspot.com
Cancer Technology and Insights: Can a vaccine help fight breast cancer?
http://cancertechinsights.blogspot.com/2008/09/can-vaccine-help-fight-breast-cancer.html
Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Sunday, September 21, 2008. Can a vaccine help fight breast cancer? A new vaccine in development targets breast cancers that proliferate aggressively in response to the growth factor HER-2. About 25-30% of women with breast cancer have HER-2 positive tumours. Herceptin (trastuzumab). The researchers published in the findings in Cancer Research. The vaccine, developed at the Karmanos Cancer Center in Detroit, u...
cancertechinsights.blogspot.com
Cancer Technology and Insights: October 2008
http://cancertechinsights.blogspot.com/2008_10_01_archive.html
Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Monday, October 6, 2008. 2008 Nobel Prize for medicine honours 3 vaccine researchers. Somewhat controversially, the Nobel committee has awarded the Prize for Physiology and Medicine to three Europeans. Harald zur Hausen. Discovered human papilloma viruses (HPV), which causes cervical cancer and two Frenchmen, Françoise Barré-Sinoussi and Luc Montagnier. In the 1990s, however, the U.S. government acknow...Nobel...
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: Trick or treat? When new therapies stretch the price barrier
http://hematologymarketinsights.blogspot.com/2008/11/trick-or-treat-when-new-therapies.html
Monday, November 3, 2008. When new therapies stretch the price barrier. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder that affects around 10,000 people globally. The red blood cells in PNH patients are weak and are destroyed more rapidly than normal. This causes the urine to turn red or dark during an episode (or paroxysm) of red cell destruction (or hemolysis). Has developed a new treatment for PNH called Soliris (eculizumab). It's hard to justify such a high price for a therapy whe...
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: September 2008
http://hematologymarketinsights.blogspot.com/2008_09_01_archive.html
Thursday, September 11, 2008. To all those who lost their lives on 9/11, there will be no blog posts today. We will remember them. Subscribe to: Posts (Atom). Pharmaceuticals, biotechnology, marketing strategy, cancer, oncology, competitive intelligence, landscape opportunity assessments, portfolio analysis. View my complete profile. Icarus Consultants, Inc. Follow Me on Twitter! Subscribe Now: Feed Icon. Subscribe in a reader. Enter your email address:. Ban academics from talking to ministers?
TOTAL LINKS TO THIS WEBSITE
87
icaruscomplex286.deviantart.com
icaruscomplex286 (Icarus Invictus) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 9 Years. Last Visit: 309 weeks ago. This deviant's activity is hidden. Deviant since Aug 3, 2007. You can drag and drop to rearrange.
Icarus Music Concerts
.:: Icarus Construction Services ::.
340 Main St, STE 840, Worcester MA 01608. ICARUS CONSTRUCTION SERVICES MISSION STATEMENT:. Backed by over fifteen-years of construction industry experience on the supervisory and project management level, Lionell D. Thompson, Jr. sought to create a general construction firm with the mission to provide value-added construction services and create successful partnerships with clients. Web Design By www.webbyguru.com.
Icarus Consultants: Pharma Marketing Strategy, New Products Consulting, Market Intelligence, KOL Market Research
Pharma New Products Strategy and Market Analysis with a focus on oncology and hematology. Icarus Custom Menu Bar. Are Checkpoint Inhibitors effective in Prostate Cancer? Will Prostate Cancer be part of the immunotherapy revolution? 2015 is the year of Gene Editing. Cellectis and other companies plan to use gene editing tools to create novel CAR-T therapies Read More. What’s exciting in Cancer Immunotherapy? Want to know what was exciting at the Society for Immunotherapy of Cancer annual meeting? We frequ...
Icarus Controlli ed Ispezioni di Annovi Ing. Gabriele
icarusconsultinginc.com
Welcome to: icarusconsultinginc.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Is this your domain? Let's turn it into a website! Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.
ICARUS CONSULTANTS INC.
Professional Marketing and Consultancy Services for the Offshore Drilling Industry:. Bi-monthly Newsletter summarizing events and activities in the Asia pacific Offshore Drilling Industry on a subscription basis. A) Facilitating and preparation of tender documents. B) Preparation of bids in response to tenders. Contract reviews, preparation of exceptions. D) Drilling Contract negotiations and contract finalization. E) Contract Administration / Contract Engineering. H) Sales and marketing of offshore rigs.
Icarus Consultants | Asia Pacific Offshore Drilling Blog
Asia Pacific Offshore Drilling Blog. Piano Player in a Whorehouse. INDONESIA – STICK OR TWIST? The latest twist in Indonesia’s ever changing regulatory regime governing drilling contracts in Indonesia is a requirement for. Well let’s throw in some of the other requirement. Then there is the propensity of the local banks to change the proscribed Bid Bond language without telling you and getting you disqualified (remember no exceptions! I mentioned earlier that contract exceptions are not allowed. This...
Home
OUR CONSULTANTS HAVE BEEN EVERYWHERE RETAIL TO WALL STREET. Our professional staff includes MBAs, .IT Architects, Developers and sales staff. Delivered everything they promised. Our customer satisfaction levels are at an all-time high!
SOCIAL ENGAGEMENT